3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
3
Recruiting
1
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Prostatic Neoplasms
12
Oropharyngeal Neoplasms
12
Head and Neck Neoplasms
7
Carcinoma, Squamous Cell
6
Nasopharyngeal Carcinoma
5
Esophageal Neoplasms
5
Rectal Neoplasms
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Oligodendroglioma
2
Myelodysplastic Syndromes
2
Lymphatic Metastasis
2
Leukemia, Myeloid, Acute
2
Hypopharyngeal Neoplasms
2
Glioblastoma
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Astrocytoma
2
Anus Neoplasms
2
Virus Diseases
1
Vaginal Neoplasms
1
Interventions
Gemcitabine
19
pembrolizumab
17
Cisplatin
17
Nivolumab
15
atezolizumab
12
Magnetic Resonance Spectroscopy
10
durvalumab
9
Specimen Handling
9
Cystectomy
9
Carboplatin
7
Ipilimumab
6
Fluorouracil
6
avelumab
5
Surgical Procedures, Operative
5
Mitomycin
5
sacituzumab govitecan
4
erdafitinib
4
enfortumab vedotin
4
Immunoglobulin G
4
Disulfides
4
Biopsy
4
tremelimumab
3
cabozantinib
3
Transurethral Resection of Bladder
3
Surveys and Questionnaires
3
Radiation
3
Platinum
3
Paclitaxel
3
Leucovorin
3
Docetaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Urinary Bladder Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT05975307
2025-12-01
BCIRT-01
Sun Yat-sen University
Phase 2
Active not recruiting
71 enrolled